PATENT CLAIM ANALYSIS

Application Number: 15743756
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-09
Patent Classification: ["530", "387300"]

Abstract:
The present disclosure relates to antibody molecules comprising a binding domain specific to CD22, said binding domain comprising SEQ ID NO: 1, 2, 3, 4, 5 and 6 or 7. The disclosure also extends to pharmaceutical compositions comprising said antibody molecules and use of the antibody molecules/compositions in treatment.

Claim (Index 18):
The antibody molecule according to  claim 3 , wherein CDRL3 has a formula (VIa): (SEQ ID NO: 22) AGYKSX 48 X 49 DX 50 X 51 TT or   (SEQ ID NO: 23) AGYKSDX 49 DDX 51 TT, or   (SEQ ID NO: 24) QX 52 YX 54 X 55 X 56 SX 57 X 58 X 59 X 60 X 61 X 62 X 63 X 64 or   (SEQ ID NO: 25) QX 52 YYX 55 X 56 SX 57 X 58 X 59 X 60 X 61 X 62 X 63 X 64 or   (SEQ ID NO: 26) QX 52 YYX 55 SSX 57 X 58 X 59 X 60 X 61 X 62 X 63 X 64 or   (SEQ ID NO: 27) QX 52 YYX 55 SSX 57 X 58 X 59 X 60 X 61 X 62 X 64 or   (SEQ ID NO: 28) QX 52 YYX 55 SSX 57 X 58 X 59 X 60 X 61 X 62 wherein X 52 , X 54 , X 55 , X 56 , X 57 , X 58 , X 59 , X 60 , X 61 , X 62 , X 63  and X 64  are as defined above for formula VII.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 86.0
- Lexical Diversity: 1.46154
- Patent Class: 530.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15743764', '15326501', '15627161', '15430998', '13107439']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7745816833997957
- 35 USC 102 Novelty (BERT): 0.6229068416058725
- Combined Prediction Score: 0.7594141992204034
- Mean Citation Score: 451.072982
- Max Citation Score: 608.11847
- Similarity Product: 467.0606154261965

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test